Farther Finance Advisors’s Cytosorbents Corp CTSO Stock Holding History

Farther Finance Advisors’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2	Hold	6	–	–	﹤0.01%	5958
2026 Q1	$3	Buy	+6	New	+$4	﹤0.01%	5724

Other funds holding CTSO

Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return

KCFA

Key Client Fiduciary Advisors Fairfield, New Jersey $347M AUM 35.3% 1-Year Est. Return

KAS

Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return

SAM

Seelaus Asset Management Chatham, New Jersey $142M AUM 48.54% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

MCM

Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Farther Finance Advisors's CTSO Position: Q2 2026 in Review

Farther Finance Advisors held its Cytosorbents Corp (CTSO) position steady in Q2 2026 at 6 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #5958.

Farther Finance Advisors first reported a position in CTSO in Q1 2026 and has held it in 2 quarters since. The position peaked at $3 in Q1 2026. 8 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

Farther Finance Advisors held 6 shares of Cytosorbents Corp worth $2 as of Q2 2026.
Farther Finance Advisors left its Cytosorbents Corp share count unchanged in Q2 2026.
Cytosorbents Corp made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5958 holding.
Farther Finance Advisors first reported a position in Cytosorbents Corp in Q1 2026 and has held it in 2 quarters since.
Farther Finance Advisors's Cytosorbents Corp position peaked at $3 in Q1 2026.
8 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.